Switch to side-by-side view

--- a
+++ b/clusters/9knumclustersv2/clust_1065.txt
@@ -0,0 +1,24 @@
+Any ongoing toxicity from prior anti-cancer therapy that is > Grade  (except hemoglobin value) and/or that is progressing in severity, except alopecia
+Grade >  toxicity (other than alopecia) continuing from prior anti-cancer therapy
+Grade >=  toxicity (other than alopecia) continuing from prior anti-cancer therapy
+Any ongoing toxicity from prior anti-cancer therapy that is > grade  and/or that is progressing in severity (except alopecia); any immuno-oncology (IO) related adverse events must be =< grade  to be eligible
+Any ongoing toxicity from prior anti-cancer therapy that is > grade  and/or that is progressing in severity, except alopecia
+Any ongoing toxicity from prior anti-cancer therapy that is greater than grade  and/or that is progressing in severity, except alopecia
+Any ongoing toxicity from prior anti-cancer therapy that is > grade  and/or that is progressing in severity (except alopecia)
+Grade >  toxicity (other than alopecia) continuing from prior anti-cancer therapy
+Any ongoing toxicity related to prior anti-cancer therapy that is > grade  and/or that is progressing in severity (exceptions include alopecia, fatigue, and hematologic toxicities)
+Any ongoing toxicity from prior anti-cancer therapy that is > grade  and/or that is progressing in severity, except alopecia
+Any ongoing toxicity from prior hormonal therapy that is > grade  and/or that is progressing in severity
+Patient must not be experiencing any ongoing toxicity from prior anti-cancer therapy that is > grade  or that is progressing in severity, except alopecia
+Any ongoing toxicity from prior anti-cancer therapy that is > grade  and/or that is progressing in severity, except alopecia
+Any ongoing toxicity from prior anti-cancer therapy that is > grade  and/or that is progressing in severity
+Any ongoing toxicity from prior investigational therapy that is > grade  and/or that is progressing in severity, except alopecia
+Any ongoing toxicity from prior anti-cancer therapy that is > grade  and/or that is progressing in severity, except alopecia
+EXPANSION COHORT ONLY: Any ongoing toxicity from prior anti-cancer therapy that is > grade  and/or that is progressing in severity; hypothyroidism treated with medication is not excluded if TSH is within normal limits
+Any ongoing toxicity from prior anti-cancer therapy that is > Grade  and/or that is progressing in severity, except alopecia.
+Any ongoing toxicity from prior anti-cancer therapy that is > Grade  and/or that is progressing in severity, except alopecia.
+Any ongoing toxicity from prior anti-cancer therapy that is > grade  and/or that is progressing in severity
+Any on-going toxicity from prior anti cancer therapy except alopecia;
+Any ongoing toxicity from prior anti-cancer therapy that is > grade  and/or that is progressing in severity, except alopecia
+Grade >  toxicity (other than alopecia) continuing from prior anti-cancer therapy
+Patient must not have any ongoing toxicity from prior anti-cancer therapy that is > grade  and/or that is progressing in severity, except alopecia